Denmark · Delayed Price · Currency is DKK BioMar Group Statistics
Total Valuation
BioMar Group has a market cap or net worth of DKK 12.18 billion. The enterprise value is 14.78 billion.
| Market Cap | 12.18B |
| Enterprise Value | 14.78B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioMar Group has 100.23 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 100.23M |
| Shares Outstanding | 100.23M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 14.64% |
| Float | 25.96M |
Valuation Ratios
The trailing PE ratio is 13.27 and the forward PE ratio is 13.10. BioMar Group's PEG ratio is 0.81.
| PE Ratio | 13.27 |
| Forward PE | 13.10 |
| PS Ratio | 0.70 |
| PB Ratio | 3.72 |
| P/TBV Ratio | 6.17 |
| P/FCF Ratio | 10.32 |
| P/OCF Ratio | 8.26 |
| PEG Ratio | 0.81 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.80, with an EV/FCF ratio of 12.51.
| EV / Earnings | 16.23 |
| EV / Sales | 0.85 |
| EV / EBITDA | 6.80 |
| EV / EBIT | 10.85 |
| EV / FCF | 12.51 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.97.
| Current Ratio | 1.16 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.97 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 2.69 |
| Interest Coverage | 7.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 16.31% |
| Return on Capital Employed (ROCE) | 22.74% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.38M |
| Profits Per Employee | 492,738 |
| Employee Count | 1,808 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioMar Group has paid 322.00 million in taxes.
| Income Tax | 322.00M |
| Effective Tax Rate | 25.86% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 126.34 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 37.62 |
| Average Volume (20 Days) | 99,351 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioMar Group had revenue of DKK 17.44 billion and earned 916.00 million in profits. Earnings per share was 9.15.
| Revenue | 17.44B |
| Gross Profit | 4.15B |
| Operating Income | 1.31B |
| Pretax Income | 1.25B |
| Net Income | 916.00M |
| EBITDA | 1.97B |
| EBIT | 1.31B |
| Earnings Per Share (EPS) | 9.15 |
Balance Sheet
The company has 598.00 million in cash and 3.20 billion in debt, with a net cash position of -2.61 billion or -25.99 per share.
| Cash & Cash Equivalents | 598.00M |
| Total Debt | 3.20B |
| Net Cash | -2.61B |
| Net Cash Per Share | -25.99 |
| Equity (Book Value) | 3.30B |
| Book Value Per Share | 32.94 |
| Working Capital | 1.08B |
Cash Flow
In the last 12 months, operating cash flow was 1.49 billion and capital expenditures -297.00 million, giving a free cash flow of 1.19 billion.
| Operating Cash Flow | 1.49B |
| Capital Expenditures | -297.00M |
| Depreciation & Amortization | 668.00M |
| Net Borrowing | 250.00M |
| Free Cash Flow | 1.19B |
| FCF Per Share | 11.86 |
Margins
Gross margin is 23.82%, with operating and profit margins of 7.49% and 5.25%.
| Gross Margin | 23.82% |
| Operating Margin | 7.49% |
| Pretax Margin | 7.14% |
| Profit Margin | 5.25% |
| EBITDA Margin | 11.32% |
| EBIT Margin | 7.49% |
| FCF Margin | 6.82% |
Dividends & Yields
BioMar Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 93.12% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.12% |
| Shareholder Yield | -0.12% |
| Earnings Yield | 7.53% |
| FCF Yield | 9.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BioMar Group is 143.80, which is 18.35% higher than the current price. The consensus rating is "Buy".
| Price Target | 143.80 |
| Price Target Difference | 18.35% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 6.01% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioMar Group has an Altman Z-Score of 2.92 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.92 |
| Piotroski F-Score | 5 |